Allergy and asthma prevention 2014

Pediatric Allergy and Immunology

Volumn 25, Issue 6, 2014, Pages 516-533

  Nieto, Antonio ^a   Wahn, Ulrich ^b   Bufe, Albrecht ^c   Eigenmann, Philippe ^d   Halken, Susanne ^e   Hedlin, Gunilla ^f   Høst, Arne ^e   Hourihane, Jonathan ^g   Just, Jocelyne ^h   Lack, Gideon ^i,j   Lau, Susanne ^b   Matricardi, Paolo Maria ^b   Muraro, Antonella ^k   Papadopoulos, Nikos ^l,m   Roberts, Graham ^n,o,p   Simpson, Angela ^q   Valovirta, Erkka ^r   Weidinger, Stephan ^s   Wickman, Magnus ^t   Mazon, Angel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY COLLEGE CORK   (Ireland)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF PADOVA   (Italy)

^l UNIVERSITY OF ATHENS   (Greece)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^o Karolinska University Hospital   (United Kingdom)

^p UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^q MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^r UNIVERSITY OF TURKU   (Finland)

^s UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^t SACHS CHILDREN S HOSPITAL   (Sweden)

more..

Author keywords

Allergy; Asthma; Atopic dermatitis; Avoidance; Environment; Food allergy; Immunotherapy; Nutrition; Prebiotics; Prevention; Probiotics; Risk factors

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BACTERIUM LYSATE; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; OMALIZUMAB; PREBIOTIC AGENT; PROBIOTIC AGENT; TOBACCO SMOKE; VIRUS VACCINE;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ARTIFICIAL MILK; ASTHMA; ATOPIC DERMATITIS; BACTERIA; BACTERIAL INFECTION; BREAST FEEDING; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; EARLY CHILDHOOD INTERVENTION; ENVIRONMENTAL EXPOSURE; FOOD ALLERGY; HIGH RISK INFANT; HUMAN; IMMUNOTHERAPY; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; LIFESTYLE; META ANALYSIS (TOPIC); NONHUMAN; OBESITY; POLLUTANT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SECONDARY PREVENTION; SENSITIZATION; SYSTEMATIC REVIEW (TOPIC); TIME; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING; ADVERSE EFFECTS; ANIMAL; DESENSITIZATION; EVIDENCE BASED MEDICINE; FEEDING BEHAVIOR; HYPERSENSITIVITY; IMMUNOLOGY; INFANT;

ALLERGENS; ANIMALS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; FOOD HABITS; HUMANS; HYPERSENSITIVITY; INFANT; INFANT FORMULA; PROBIOTICS;

EID: 84922803093     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12272     Document Type: Article

References (204)

1. Prescott SL. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol 2013: 131: 23-30.
2. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999: 353: 1485-8.
3. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012: 18: 726-35.
4. Liu X, Zhang S, Tsai HJ, et al. Genetic and environmental contributions to allergen sensitization in a Chinese twin study. Clin Exp Allergy 2009: 39: 991-8.
5. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012: 129: 735-44.
6. Mitchell EA, Beasley R, Keil U, Montefort S, Odhiambo J. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme. Thorax 2012: 67: 941-9.
7. Neuman A, Hohmann C, Orsini N, et al. Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med 2012: 186: 1037-43.
8. Xepapadaki P, Manios Y, Liarigkovinos T, et al. Association of passive exposure of pregnant women to environmental tobacco smoke with asthma symptoms in children. Pediatr Allergy Immunol 2009: 20: 423-9.
9. Grabenhenrich LB, Gough H, Reich A, et al. Early-life determinants of asthma from birth to age 20 years: a German birth cohort study. J Allergy Clin Immunol 2014: 133: 979-88 e3.
10. Host A, Halken S, Muraro A, et al. Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol 2008: 19: 1-4.
11. Simpson A, John SL, Jury F, et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med 2006: 174: 386-92.
12. Scott M, Roberts G, Kurukulaaratchy RJ, Matthews S, Nove A, Arshad SH. Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years. Thorax 2012: 67: 1046-51.
13. Papadopoulos NG, Borres M, Gern J, Nieto A. New visions in respiratory allergy (asthma and allergic rhinitis): an iPAC summary and future trends. Pediatr Allergy Immunol 2008: 19(Suppl 19): 51-9.
14. Simpson A, Tan VY, Winn J, et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 2010: 181: 1200-6.
15. Just J, Saint-Pierre P, Gouvis-Echraghi R, et al. Wheeze phenotypes in young children have different courses during the preschool period. Ann Allergy Asthma Immunol 2013: 111: 256-61 e1.
16. Just J, Gouvis-Echraghi R, Couderc R, Guillemot-Lambert N, Saint-Pierre P. Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol 2012: 130: 103-10 e8.
17. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012: 18: 716-25.
18. Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. J Allergy Clin Immunol 2010: 125: S81-94.
19. Lovinsky-Desir S, Miller RL. Epigenetics, asthma, and allergic diseases: a review of the latest advancements. Curr Allergy Asthma Rep 2012: 12: 211-20.
20. Simpson A, Custovic A. Early pet exposure: friend or foe? Curr Opin Allergy Clin Immunol 2003: 3: 7-14.
21. Celedon JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR. Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet 2002: 360: 781-2.
22. Kulig M, Luck W, Lau S, et al. Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy 1999: 54: 220-8.
23. Custovic A, Simpson BM, Simpson A, Kissen P, Woodcock A. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet 2001: 358: 188-93.
24. Lodrup Carlsen KC, Roll S, Carlsen KH, et al. Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts PLoS ONE 2012: 7: e43214.
25. Bisgaard H, Simpson A, Palmer CN, et al. Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med 2008: 5: e131.
26. Brunekreef B, Groot B, Hoek G. Pets, allergy and respiratory symptoms in children. Int J Epidemiol 1992: 21: 338-42.
27. Anyo G, Brunekreef B, de Meer G, Aarts F, Janssen NA, van Vliet P. Early, current and past pet ownership: associations with sensitization, bronchial responsiveness and allergic symptoms in school children. Clin Exp Allergy 2002: 32: 361-6.
28. Bornehag CG, Sundell J, Hagerhed L, Janson S. Pet-keeping in early childhood and airway, nose and skin symptoms later in life. Allergy 2003: 58: 939-44.
29. Almqvist C, Larsson PH, Egmar AC, Hedren M, Malmberg P, Wickman M. School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes. J Allergy Clin Immunol 1999: 103: 1012-17.
30. Custovic A, Green R, Taggart SC, et al. Domestic allergens in public places. II: Dog (Can f1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings. Clin Exp Allergy 1996: 26: 1246-52.
31. Munir AK, Einarsson R, Dreborg S. Variability of airborne cat allergen, Fel d1, in a public place. Indoor Air 2003: 13: 353-8.
32. Lau S, Falkenhorst G, Weber A, et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol 1989: 84: 718-25.
33. Brussee JE, Smit HA, van Strien RT, et al. Allergen exposure in infancy and the development of sensitization, wheeze, and asthma at 4 years. J Allergy Clin Immunol 2005: 115: 946-52.
34. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990: 323: 502-7.
35. Tovey ER, Almqvist C, Li Q, Crisafulli D, Marks GB. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J Allergy Clin Immunol 2008: 122: 114-18, 18 e1-5.
36. Cullinan P, MacNeill SJ, Harris JM, et al. Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children: a cohort study. Thorax 2004: 59: 855-61.
37. Tovey ER, Marks GB. It's time to rethink mite allergen avoidance. J Allergy Clin Immunol 2011: 128: 723-27 e6.
38. Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000: 356: 1392-7.
39. Genuneit J. Exposure to farming environments in childhood and asthma and wheeze in rural populations: a systematic review with meta-analysis. Pediatr Allergy Immunol 2012: 23: 509-18.
40. Brunekreef B, Von Mutius E, Wong GK, Odhiambo JA, Clayton TO. Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study. Int J Epidemiol 2012: 41: 753-61.
41. Perkin MR, Strachan DP. Which aspects of the farming lifestyle explain the inverse association with childhood allergy? J Allergy Clin Immunol 2006: 117: 1374-81.
42. Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011: 364: 701-9.
43. Horak F Jr, Matthews S, Ihorst G, et al. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study - 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy 2004: 34: 1220-5.
44. Woodcock A, Lowe LA, Murray CS, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 2004: 170: 433-9.
45. Corver K, Kerkhof M, Brussee JE, et al. House dust mite allergen reduction and allergy at 4 yr: follow up of the PIAMA-study. Pediatr Allergy Immunol 2006: 17: 329-36.
46. Marks GB, Mihrshahi S, Kemp AS, et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol 2006: 118: 53-61.
47. Arshad SH, Bojarskas J, Tsitoura S, et al. Prevention of sensitization to house dust mite by allergen avoidance in school age children: a randomized controlled study. Clin Exp Allergy 2002: 32: 843-9.
48. Tsitoura S, Nestoridou K, Botis P, et al. Randomized trial to prevent sensitization to mite allergens in toddlers and preschoolers by allergen reduction and education: one-year results. Arch Pediatr Adolesc Med 2002: 156: 1021-7.
49. Chan-Yeung M, Ferguson A, Watson W, et al. The Canadian childhood asthma primary prevention study: outcomes at 7 years of age. J Allergy Clin Immunol 2005: 116: 49-55.
50. Maas T, Dompeling E, Muris JW, Wesseling G, Knottnerus JA, van Schayck OC. Prevention of asthma in genetically susceptible children: a multifaceted intervention trial focussed on feasibility in general practice. Pediatr Allergy Immunol 2011: 22: 794-802.
51. Maas T, Kaper J, Sheikh A, et al. Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma. Cochrane Database Syst Rev 2009: CD006480.
52. Berge M, Munir AK, Dreborg S. Concentrations of cat (Fel d1), dog (Can f1) and mite (Der f1 and Der p1) allergens in the clothing and school environment of Swedish schoolchildren with and without pets at home. Pediatr Allergy Immunol 1998: 9: 25-30.
53. Jacquemin B, Kauffmann F, Pin I, et al. Air pollution and asthma control in the Epidemiological study on the Genetics and Environment of Asthma. J Epidemiol Community Health 2012: 66: 796-802.
54. Mortimer K, Neugebauer R, Lurmann F, Alcorn S, Balmes J, Tager I. Air pollution and pulmonary function in asthmatic children: effects of prenatal and lifetime exposures. Epidemiology 2008: 19: 550-7; discussion 61-2.
55. McConnell R, Berhane K, Yao L, et al. Traffic, susceptibility, and childhood asthma. Environ Health Perspect 2006: 114: 766-72.
56. Morgenstern V, Zutavern A, Cyrys J, et al. Respiratory health and individual estimated exposure to traffic-related air pollutants in a cohort of young children. Occup Environ Med 2007: 64: 8-16.
57. Ryan PH, LeMasters G, Biagini J, et al. Is it traffic type, volume, or distance? Wheezing in infants living near truck and bus traffic. J Allergy Clin Immunol 2005: 116: 279-84.
58. Anderson HR, Ruggles R, Pandey KD, et al. Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: phase one of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med 2010: 67: 293-300.
59. Molter A, Agius R, de Vocht F, et al. Effects of long-term exposure to PM10 and NO2 on asthma and wheeze in a prospective birth cohort. J Epidemiol Community Health 2014: 68: 21-8.
60. Kalliola S, Pelkonen AS, Malmberg LP, et al. Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheeze. J Allergy Clin Immunol 2013: 131: 730-5.
61. Anderson HR, Favarato G, Atkinson R. Long-term exposure to outdoor air pollution and the prevalence of asthma: meta-analysis of multi-community prevalence studies. Air Qual Atmos Health 2013: 6: 57-68.
62. Kohli A, Garcia MA, Miller RL, et al. Secondhand smoke in combination with ambient air pollution exposure is associated with increased CpG methylation and decreased expression of IFN-gamma in T effector cells and Foxp3 in T regulatory cells in children. Clin Epigenetics 2012: 4: 17.
63. Mitchell EA, Beasley R, Bjorksten B, Crane J, Garcia-Marcos L, Keil U. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy 2013: 43: 73-84.
64. Rzehak P, Wijga AH, Keil T, et al. Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts-a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol 2013: 131: 1528-36.
65. Magnusson JO, Kull I, Mai XM, Wickman M, Bergstrom A. Early childhood overweight and asthma and allergic sensitization at 8 years of age. Pediatrics 2012: 129: 70-6.
66. Flaherman V, Rutherford GW. A meta-analysis of the effect of high weight on asthma. Arch Dis Child 2006: 91: 334-9.
67. Guibas GV, Manios Y, Xepapadaki P, et al. The obesity-asthma link in different ages and the role of body mass index in its investigation: findings from the Genesis and Healthy Growth Studies. Allergy 2013: 68: 1298-305.
68. Sherriff A, Maitra A, Ness AR, et al. Association of duration of television viewing in early childhood with the subsequent development of asthma. Thorax 2009: 64: 321-5.
69. Saarinen KM, Juntunen-Backman K, Jarvenpaa AL, et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. J Allergy Clin Immunol 1999: 104: 457-61.
70. Wetzig H, Schulz R, Diez U, Herbarth O, Viehweg B, Borte M. Associations between duration of breast-feeding, sensitization to hens' eggs and eczema infantum in one and two year old children at high risk of atopy. Int J Hyg Environ Health 2000: 203: 17-21.
71. van Odijk J, Kull I, Borres MP, et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy 2003: 58: 833-43.
72. de Silva D, Geromi M, Halken S, et al. Primary prevention of food allergy in children and adults: systematic review. Allergy 2014: 69: 581-9.
73. Muraro A, Halken S, Arshad SH, et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014: 69: 590-601.
74. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2012: 9: CD000133.
75. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2006: CD003664.
76. Lodge CJ, Allen KJ, Lowe AJ, Dharmage SC. Overview of evidence in prevention and aetiology of food allergy: a review of systematic reviews. Int J Environ Res Public Health 2013: 10: 5781-806.
77. von Berg A, Filipiak-Pittroff B, Kramer U, et al. Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study. J Allergy Clin Immunol 2013: 131: 1565-73.
78. Muraro A, Dreborg S, Halken S, et al. Dietary prevention of allergic diseases in infants and small children. Part III: critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immunol 2004: 15: 291-307.
79. Zutavern A, von Mutius E, Harris J, et al. The introduction of solids in relation to asthma and eczema. Arch Dis Child 2004: 89: 303-8.
80. Joseph CL, Ownby DR, Havstad SL, et al. Early complementary feeding and risk of food sensitization in a birth cohort. J Allergy Clin Immunol 2011: 127: 1203-10 e5.
81. Nwaru BI, Erkkola M, Ahonen S, et al. Age at the introduction of solid foods during the first year and allergic sensitization at age 5 years. Pediatrics 2010: 125: 50-9.
82. Grimshaw KE, Maskell J, Oliver EM, et al. Diet and food allergy development during infancy: birth cohort study findings using prospective food diary data. J Allergy Clin Immunol 2014: 133: 511-19.
83. Grimshaw KE, Maskell J, Oliver EM, et al. Introduction of complementary foods and the relationship to food allergy. Pediatrics 2013: 132: e1529-38.
84. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012: 129: 434-40, 40 e1-2.
85. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007: 62: 1223-36.
86. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 2013: 131: 346-52 e1-3.
87. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997: 159: 1739-45.
88. Geuking MB, Cahenzli J, Lawson MA, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011: 34: 794-806.
89. Debarry J, Garn H, Hanuszkiewicz A, et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 2007: 119: 1514-21.
90. Pfefferle PI, Prescott SL, Kopp M. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J Allergy Clin Immunol 2013: 131: 1453-63; quiz 64.
91. Lau S, Gerhold K, Zimmermann K, et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2012: 129: 1040-7.
92. Gruber C, van Stuijvenberg M, Mosca F, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010: 126: 791-7.
93. Morisset M, Aubert-Jacquin C, Soulaines P, Moneret-Vautrin DA, Dupont C. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur J Clin Nutr 2011: 65: 175-83.
94. Konieczna P, Akdis CA, Quigley EM, Shanahan F, O'Mahony L. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 2012: 3: 261-6.
95. Niers L, Martin R, Rijkers G, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009: 64: 1349-58.
96. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007: CD006475.
97. Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood-a meta-analysis. Br J Nutr 2012: 107: 1-6.
98. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012: 23: 402-14.
99. Dang D, Zhou W, Lun ZJ, Mu X, Wang DX, Wu H. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J Int Med Res 2013: 41: 1426-36.
100. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013: 132: e666-76.
101. Osborn DA, Sinn J. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 2013: CD006474.
102. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002: 347: 869-77.
103. Ege MJ, Bieli C, Frei R, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006: 117: 817-23.
104. Roduit C, Wohlgensinger J, Frei R, et al. Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis. J Allergy Clin Immunol 2011: 127: 179-85, 85 e1.
105. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001: 358: 1129-33.
106. Ahrens B, Quarcoo D, Buhner S, Matricardi PM, Hamelmann E. Oral administration of bacterial lysates attenuates experimental food allergy. Int Arch Allergy Immunol 2011: 156: 196-204.
107. Debarry J, Hanuszkiewicz A, Stein K, Holst O, Heine H. The allergy-protective properties of Acinetobacter lwoffii F78 are imparted by its lipopolysaccharide. Allergy 2010: 65: 690-7.
108. Gerhold K, Avagyan A, Seib C, et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 2006: 118: 666-73.
109. Stiehm M, Peters K, Wiesmuller KH, Bufe A, Peters M. A novel synthetic lipopeptide is allergy-protective by the induction of LPS-tolerance. Clin Exp Allergy 2013: 43: 785-97.
110. Peters M, Kauth M, Schwarze J, et al. Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness. Thorax 2006: 61: 134-9.
111. Peters M, Kauth M, Scherner O, et al. Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization. J Allergy Clin Immunol 2010: 126: 648-56 e1-4.
112. Stiehm M, Bufe A, Peters M. Proteolytic activity in cowshed dust extracts induces C5a release in murine bronchoalveolar lavage fluids which may account for its protective properties in allergic airway inflammation. Thorax 2013: 68: 31-8.
113. Prescott S, Saffery R. The role of epigenetic dysregulation in the epidemic of allergic disease. Clin Epigenetics 2011: 2: 223-32.
114. Enioutina EY, Bareyan D, Daynes RA. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009: 182: 4296-305.
115. West CE, Dunstan J, McCarthy S, et al. Associations between maternal antioxidant intakes in pregnancy and infant allergic outcomes. Nutrients 2012: 4: 1747-58.
116. Litonjua AA, Rifas-Shiman SL, Ly NP, et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr 2006: 84: 903-11.
117. Devereux G, Turner SW, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006: 174: 499-507.
118. Shaheen SO, Newson RB, Henderson AJ, Emmett PM, Sherriff A, Cooke M. Umbilical cord trace elements and minerals and risk of early childhood wheezing and eczema. Eur Respir J 2004: 24: 292-7.
119. Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol 2011: 127: 724-33 e1-30.
120. Garcia-Marcos L, Castro-Rodriguez JA, Weinmayr G, Panagiotakos DB, Priftis KN, Nagel G. Influence of Mediterranean diet on asthma in children: a systematic review and meta-analysis. Pediatr Allergy Immunol 2013: 24: 330-8.
121. Rosenlund H, Magnusson J, Kull I, et al. Antioxidant intake and allergic disease in children. Clin Exp Allergy 2012: 42: 1491-500.
122. Jones AP, Palmer D, Zhang G, Prescott SL. Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy. Pediatrics 2012: 130: e1128-35.
123. Nwaru BI, Ahonen S, Kaila M, et al. Maternal diet during pregnancy and allergic sensitization in the offspring by 5 yrs of age: a prospective cohort study. Pediatr Allergy Immunol 2010: 21: 29-37.
124. Maslova E, Hansen S, Jensen CB, Thorne-Lyman AL, Strom M, Olsen SF. Vitamin D intake in mid-pregnancy and child allergic disease - a prospective study in 44, 825 Danish mother-child pairs. BMC Pregnancy Childbirth 2013: 13: 199.
125. Weisse K, Winkler S, Hirche F, et al. Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy 2013: 68: 220-8.
126. Back O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 2009: 89: 28-32.
127. Chawes BL, Bonnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS ONE 2014: 9: e99856.
128. Pike KC, Inskip HM, Robinson S, et al. Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes. Thorax 2012: 67: 950-6.
129. Goldring ST, Griffiths CJ, Martineau AR, et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS ONE 2013: 8: e66627.
130. Palmer DJ, Sullivan T, Gold MS, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 2012: 344: e184.
131. D'Vaz N, Meldrum SJ, Dunstan JA, et al. Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial. Pediatrics 2012: 130: 674-82.
132. Subrata LS, Bizzintino J, Mamessier E, et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009: 183: 2793-800.
133. Semic-Jusufagic A, Belgrave D, Pickles A, et al. Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study. Lancet Respir Med 2014: 2: 621-30.
134. Papadopoulos NG, Papi A, Psarras S, Johnston SL. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev 2004: 5: 255-60.
135. Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2012: 130: 91-100 e3.
136. Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010: 65: 1045-52.
137. Mikalsen IB, Halvorsen T, Oymar K. The outcome after severe bronchiolitis is related to gender and virus. Pediatr Allergy Immunol 2012: 23: 391-8.
138. Thomsen SF, van der Sluis S, Stensballe LG, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009: 179: 1091-7.
139. Caliskan M, Bochkov YA, Kreiner-Moller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013: 368: 1398-407.
140. Shadman KA, Wald ER. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther 2011: 11: 1455-67.
141. Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013: 368: 1791-9.
142. Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010: 126: 256-62.
143. Gaboli M, de la Cruz OA, de Aguero MI, Moreno-Galdo A, Perez GP, de Querol MS. Use of palivizumab in infants and young children with severe respiratory disease: a delphi study. Pediatr Pulmonol 2014: 49(5): 490-502.
144. Lee KK, Hegele RG, Manfreda J, et al. Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. Pediatr Pulmonol 2007: 42: 290-7.
145. Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007: 119: 1105-10.
146. Bossios A, Gourgiotis D, Skevaki CL, et al. Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin Exp Allergy 2008: 38: 1615-26.
147. McLean GR, Walton RP, Shetty S, et al. Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. Antiviral Res 2012: 95: 193-201.
148. Edlmayr J, Niespodziana K, Linhart B, et al. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 2009: 182: 6298-306.
149. Bueving HJ. Is influenza vaccination in asthmatic children helpful? Clin Exp Allergy 2006: 36: 21-5.
150. Rusconi F, Gagliardi L, Galassi C, et al. Paracetamol and antibiotics in childhood and subsequent development of wheezing/asthma: association or causation? Int J Epidemiol 2011: 40: 662-7.
151. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013: 162: 832-38 e3.
152. Almqvist C, Wettermark B, Hedlin G, Ye W, Lundholm C. Antibiotics and asthma medication in a large register-based cohort study - confounding, cause and effect. Clin Exp Allergy 2012: 42: 104-11.
153. Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations-a GA(2) LEN-DARE systematic review. Allergy 2011: 66: 458-68.
154. Caramori G, Papadopoulos N, Contoli M, et al. Asthma: a chronic infectious disease? Clin Chest Med 2012: 33: 473-84.
155. Schwerk N, Brinkmann F, Soudah B, Kabesch M, Hansen G. Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy. PLoS ONE 2011: 6: e27913.
156. Brand PL, Caudri D, Eber E, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014: 43: 1172-7.
157. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006: 368: 754-62.
158. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009: 360: 339-53.
159. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006: 354: 1998-2005.
160. Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011: 377: 650-7.
161. Nair P. Early interventions with inhaled corticosteroids in asthma: benefits and risks. Curr Opin Pulm Med 2011: 17: 12-15.
162. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007: 62: 943-8.
163. Kessel A, Halloun H, Bamberger E, Kugelman A, Toubi E. Abnormal spirometry in children with persistent allergic rhinitis due to mite sensitization: the benefit of nasal corticosteroids. Pediatr Allergy Immunol 2008: 19: 61-6.
164. Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004: 92: 438-45.
165. Bustos GJ, Bustos D, Romero O. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995: 25: 568-73.
166. Iikura Y, Naspitz CK, Mikawa H, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992: 68: 233-6.
167. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001: 108: 929-37.
168. Simons FE, Early Prevention of Asthma in Atopic Children Study G. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 2007: 18: 535-42.
169. Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol 2010: 63: 587-93.
170. Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011: 364: 1005-15.
171. Nakamura T, Kloetzer WS, Brams P, et al. In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. Int J Immunopharmacol 2000: 22: 131-41.
172. Nopp A, Johansson SG, Ankerst J, Palmqvist M, Oman H. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment. Allergy 2007: 62: 1175-81.
173. Busse WW, Trzaskoma B, Omachi TA, Canvin J, Rosen K, Chipps BE, Luskin AT, Solari PG. Evaluating Xolair persistency of response after long-term therapy (Xport). Am J Respir Crit Care Med 2014: 189: A6576 (abstract)
174. Riccio AM, Dal Negro RW, Micheletto C, et al. Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. Int J Immunopathol Pharmacol 2012: 25: 475-84.
175. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011: 128: 1165-74.
176. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010: CD001186.
177. Larenas-Linnemann D. Sublingual immunotherapy in children: complete and updated review supporting evidence of effect. Curr Opin Allergy Clin Immunol 2009: 9: 168-76.
178. Larenas-Linnemann DE, Pietropaolo-Cienfuegos DR, Calderon MA. Evidence of effect of subcutaneous immunotherapy in children: complete and updated review from 2006 onward. Ann Allergy Asthma Immunol 2011: 107: 407-16 e11.
179. Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008: 133: 599-609.
180. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006: 117: 263-8.
181. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006: 61: 198-201.
182. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002: 57: 306-12.
183. Hedlin G, Heilborn H, Lilja G, et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995: 96: 879-85.
184. Holt PG, Sly PD, Sampson HA, et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. J Allergy Clin Immunol 2013: 132: 991-3 e1.
185. Zolkipli Z, Roberts G, Cornelius V, et al. Randomised controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. Allergy in press: still in press.
186. Kurukulaaratchy RJ, Raza A, Scott M, et al. Characterisation of asthma that develops during adolescence; findings from the Isle of Wight Birth Cohort. Respir Med 2012: 106: 329-37.
187. Jacobsen L, Wahn U, Bilo MB. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy 2012: 2: 8.
188. Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000: 162: 2048-52.
189. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002: 109: 251-6.
190. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004: 114: 851-7.
191. Marogna M, Tomassetti D, Bernasconi A, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008: 101: 206-11.
192. Valovirta E, Berstad AK, de Blic J, et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis. Clin Ther 2011: 33: 1537-46.
193. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997: 99: 450-3.
194. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001: 31: 1392-7.
195. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001: 31: 1295-302.
196. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004: 59: 1205-10.
197. Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012: 130: 894-901 e5.
198. Matricardi PM. Allergen-specific immunoprophylaxis: toward secondary prevention of allergic rhinitis? Pediatr Allergy Immunol 2014: 25: 15-18.
199. Canonica GW, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009: 64(Suppl 91): 1-59.
200. Calderon MA, Demoly P, Gerth van Wijk R, et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy 2012: 2: 20.
201. Papadopoulos NG, Agache I, Bavbek S, et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy 2012: 2: 21.
202. Muraro A, Dreborg S, Halken S, et al. Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatr Allergy Immunol 2004: 15: 196-205.
203. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006: 61: 663-70.
204. Haahtela T, Valovirta E, Kauppi P, et al. The Finnish Allergy Programme 2008-2018 - scientific rationale and practical implementation. Asia Pac Allergy 2012: 2: 275-9.